When did Sagimet Biosciences (SGMT) last report earnings?

Sagimet Biosciences last reported on Aug 13, 2025, covering fiscal Q2 2025.

Did SGMT beat earnings estimates?

Yes. Sagimet Biosciences reported EPS of −$0.32 for Q2 2025 against a −$0.51 estimate — a 37.05% beat.

Sagimet Biosciences (SGMT) earnings history

Most recent quarter

Fiscal period: Q2 2025
Period end: Jun 30, 2025
EPS actual: −$0.32
EPS estimate: −$0.51
EPS surprise: +37.05%
Revenue surprise: +0.00%
Revenue: $0.00
Revenue estimate: $0.00
Reported: Aug 13, 2025
SEC filing: View filing

Earnings history

Period	Reported	EPS estimate	EPS actual	Surprise	Revenue	Filing
Q2 2025	Aug 13, 2025	−$0.51	−$0.32	+37.05%	$0.00	SEC
Q1 2025	May 8, 2025	−$0.67	−$0.56	+15.90%	$0.00	SEC
Q4 2024	Mar 12, 2025	−$0.62	−$0.50	+19.52%	$0.00	SEC
Q3 2024	Nov 14, 2024	−$0.39	−$0.45	−15.95%	$0.00	SEC
Q2 2024	Aug 14, 2024	−$0.33	−$0.25	+24.63%	$0.00	SEC

Quarterly revenue

Q2 2024

$0.00

Q3 2024

$0.00

Q4 2024

$0.00

Q1 2025

$0.00

Q2 2025

$0.00

Frequently asked questions

When did Sagimet Biosciences (SGMT) last report earnings?
Sagimet Biosciences last reported on Aug 13, 2025, covering fiscal Q2 2025.
Did SGMT beat earnings estimates?
Yes. Sagimet Biosciences reported EPS of −$0.32 for Q2 2025 against a −$0.51 estimate — a 37.05% beat.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by